Your session is about to expire
← Back to Search
IV Citalopram + TMS for Depression
Study Summary
This trial will study the effects of a medication and transcranial magnetic stimulation on people with Major Depressive Disorder.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't taken any brain-affecting meds for 10 days, except fluoxetine which I stopped 5 weeks ago.I haven't taken antidepressants, anticonvulsants, or similar medications in the last 30 days.I have had ECT in the last 6 months or TMS did not help my depression.I am not taking any medications from a specific list, except for topical corticosteroids.I have no major health issues found in physical exams or lab tests.My current medication does not affect brain function or interfere with the study.I have been treated with IV CIT before.I am not pregnant, breastfeeding, and I use reliable birth control.I am between 21 and 55 years old.I have a history of epilepsy, seizures, or severe head injury.You have another mental health condition like anxiety or psychosis, or your depression is caused by a medical condition or substance use.I am currently taking medication that affects my brain function.You are currently using illegal drugs.I have been diagnosed with major depression and scored over 17 on a depression scale.I have had thoughts about harming myself.I have a medical condition that affects my brain function or could be causing my depression.I have tried at least two antidepressants without remission in my current episode.I have a history of brain conditions that could affect study results.You have had an allergic reaction or could not tolerate citalopram in any form.
Frequently Asked Questions
Am I eligible to contribute to this research endeavor?
"This investigation seeks 30 individuals with depression aged between 21 and 55. To qualify, prospective participants must have already attempted to find remission through two antidepressant medications (Vasavada et al., 2016) in their current episode, abstain from any neural-altering drugs for at least ten days (except fluoxetine which requires a five-week washout), satisfy DSM-V criteria of Major Depressive Disorder as assessed by the Mini International Neuropsychiatric Interview and score higher than 17 on the Hamilton Depression Rating Scale (Hamilton 1960)."
Is this trial actively seeking participants?
"Clinicaltrials.gov indicates that, as of the most recent update on May 17th 2022, this medical trial is not actively recruiting participants. Despite this inactivity, 1298 other clinical trials are still enrolling patients at present."
Is the age qualification for this experiment restricted to those under 50 years old?
"As per the criteria for this research, applicants aged 21-55 are eligible to participate. There is a total of 193 trials available for those below 18 and 970 studies open to individuals older than 65 years old."
Share this study with friends
Copy Link
Messenger